Stephan A. Kaeser

Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

Rebecca Radde, Tristan Bolmont, Stephan A. Kaeser et al. · EMBO Reports · 2006 · 983 citations · Full text

Neurodegenerative Diseases, Robust Pathology, Degenerative Pathology +9

Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

Melanie Meyer‐Luehmann, Janaky Coomaraswamy, Tristan Bolmont et al. · Science · 2006 · 937 citations · Full text

Brain Extracts, Immunology, Neurochemical Biomarkers +20

Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis

Yvonne S. Eisele, Ulrike Obermüller, Götz Heilbronner et al. · Science · 2010 · 554 citations

Neurodegenerative Diseases, Neurobiology Of Disease, β-Amyloid-rich Extracts +13

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

Niklas Mattsson, Ulf Andréasson, Staffan Persson et al. · Alzheimer s & Dementia · 2011 · 406 citations · Full text

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases

Mehtap Bacioglu, Luı́s F. Maia, Oliver Preische et al. · Neuron · 2016 · 402 citations · Full text

Neurodegenerative Diseases, Neurofilament Light Chain, Disease Progression +11